左旋多巴引起的低血压。
Hypotension caused by L-dopa.
作者信息
Calne D B, Brennan J, Spiers A S, Stern G M
出版信息
Br Med J. 1970 Feb 21;1(5694):474-5. doi: 10.1136/bmj.1.5694.474.
Abstract
In 20 patients with idiopathic Parkinsonism maximum tolerated doses of L-dopa were found to induce a mean reduction in blood pressure (erect systolic) of 19.3 mm.Hg, without any significant change in pulse rate. This hypotension may be due to dopamine, acting on adrenergic nerve endings or on the central nervous system itself.
摘要
在20例特发性帕金森病患者中，发现左旋多巴的最大耐受剂量可使平均血压（直立位收缩压）降低19.3毫米汞柱，而脉率无显著变化。这种低血压可能是由于多巴胺作用于肾上腺素能神经末梢或中枢神经系统本身所致。
相似文献
1
Hypotension caused by L-dopa.左旋多巴引起的低血压。
Br Med J. 1970 Feb 21;1(5694):474-5. doi: 10.1136/bmj.1.5694.474.
2
Action of dopamine on the human iris.多巴胺对人虹膜的作用。
Br Med J. 1969 Nov 8;4(5679):333-5. doi: 10.1136/bmj.4.5679.333.
3
Parkinsonism and the hypotension caused by L-dopa.帕金森综合征与左旋多巴引起的低血压。
Am Heart J. 1971 Oct;82(4):570-2. doi: 10.1016/0002-8703(71)90245-6.
4
L-Dopa and Parkinsonism.
Nature. 1970 Apr 4;226(5240):21-4. doi: 10.1038/226021a0.
5
The effects of dopamine, L-dopa, L-tyrosine, and pyridoxine on sympathetic nerve endings in man.多巴胺、左旋多巴、左旋酪氨酸和吡哆醇对人体交感神经末梢的作用。
Br J Pharmacol. 1970 May;39(1):195P-196P.
6
L-dopa in idiopathic parkinsonism.
Lancet. 1969 Nov 8;2(7628):973-6. doi: 10.1016/s0140-6736(69)90536-4.
7
Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.L-甲基多巴肼对接受左旋多巴治疗患者血压的作用
Br J Pharmacol. 1972 Jan;44(1):162-4. doi: 10.1111/j.1476-5381.1972.tb07249.x.
8
Miosis during L-dopa therapy.左旋多巴治疗期间的瞳孔缩小。
Br Med J. 1970 Jun 13;2(5710):639-40. doi: 10.1136/bmj.2.5710.639.
9
Treatment of severe parkinsonism with L-dopa.左旋多巴治疗重度帕金森病
S Afr Med J. 1971 May 8;45(18):504-7.
10
Hypotension caused by L-dopa.左旋多巴引起的低血压。
Br Med J. 1970 Jul 4;3(5713):47. doi: 10.1136/bmj.3.5713.47.
引用本文的文献
1
Wearable multimodal sensing for quantifying the cardiovascular autonomic effects of levodopa in parkinsonism.用于量化左旋多巴对帕金森病心血管自主神经影响的可穿戴多模态传感技术。
Front Netw Physiol. 2025 Apr 24;5:1543838. doi: 10.3389/fnetp.2025.1543838. eCollection 2025.
2
Association Between Levodopa with Inotrope Prescription and Mechanical Ventilation Dependence in People with Parkinson's Disease upon Septic Shock.左旋多巴与血管活性药物联用处方与帕金森病患者感染性休克后机械通气依赖的关系
J Clin Med. 2025 Jan 24;14(3):748. doi: 10.3390/jcm14030748.
3
Impacts of gait freeze on quality of life in Parkinson's disease, from the perspectives of patients and their carers.从患者及其照料者的角度看步态冻结对帕金森病患者生活质量的影响。
Ir J Med Sci. 2024 Aug;193(4):2041-2050. doi: 10.1007/s11845-024-03673-x. Epub 2024 Apr 19.
4
Levodopa-Carbidopa Intestinal Gel Improves Symptoms of Orthostatic Hypotension in Patients with Parkinson's Disease-Prospective Pilot Interventional Study.左旋多巴-卡比多巴肠凝胶改善帕金森病患者体位性低血压症状——前瞻性试点干预研究
J Pers Med. 2022 Apr 29;12(5):718. doi: 10.3390/jpm12050718.
5
Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis.直立性低血压与抗帕金森病药物：系统评价和荟萃分析。
J Geriatr Psychiatry Neurol. 2022 Sep;35(5):639-654. doi: 10.1177/08919887211060017. Epub 2021 Dec 29.
6
Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for Falls.老年人帕金森病与体位性低血压：跌倒风险因素的识别与管理
Aging Dis. 2020 May 9;11(3):679-691. doi: 10.14336/AD.2019.0805. eCollection 2020 May.
7
Reduced central sympathetic activity in Parkinson's disease.帕金森病患者的中枢交感神经活性降低。
Brain Behav. 2019 Dec;9(12):e01463. doi: 10.1002/brb3.1463. Epub 2019 Nov 5.
8
Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer.帕金森病中的神经源性直立性低血压：入门指南。
Neurol Ther. 2019 Dec;8(2):307-324. doi: 10.1007/s40120-019-00152-9. Epub 2019 Aug 27.
9
Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson's disease.底丘脑核刺激和左旋多巴调节帕金森病患者的心血管自主功能。
Sci Rep. 2017 Aug 1;7(1):7012. doi: 10.1038/s41598-017-07429-9.
10
Orthostatic stability with intravenous levodopa.静脉注射左旋多巴后的直立稳定性。
PeerJ. 2015 Aug 27;3:e1198. doi: 10.7717/peerj.1198. eCollection 2015.
本文引用的文献
1
A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study.一种与直立性低血压相关的神经综合征：一项临床病理研究。
Arch Neurol. 1960 May;2:511-27. doi: 10.1001/archneur.1960.03840110025004.
2
NOREPINEPHRINE SYNTHESIS AND RELEASE IN VIVO MEDIATED BY 3,4-DIHYDROXYPHENETHYLAMINE.由3,4-二羟基苯乙胺介导的体内去甲肾上腺素合成与释放
J Pharmacol Exp Ther. 1963 Nov;142:157-62.
3
Effects of several monoamine oxidase inhibitors on the cardiovascular actions of naturally occurring amines in the dog.几种单胺氧化酶抑制剂对犬体内天然存在胺类物质心血管作用的影响。
J Pharmacol Exp Ther. 1959 Nov;127:212-8.
4
The action of sympathomimetic amines in animals treated with reserpine.交感神经胺在接受利血平治疗的动物体内的作用。
J Physiol. 1958 Dec 4;144(2):314-36. doi: 10.1113/jphysiol.1958.sp006104.
5
The potential role of dopamine in the treatment of shock.多巴胺在休克治疗中的潜在作用。
Prog Cardiovasc Dis. 1969 Jul;12(1):40-51. doi: 10.1016/0033-0620(69)90034-6.
6
Renin-aldosterone system in Parkinson's disease.帕金森病中的肾素-醛固酮系统。
Science. 1969 Jul 18;165(3890):291-2. doi: 10.1126/science.165.3890.291.
7
The release of 3H-dopamine from the isolated rabbit ileum.从离体兔回肠释放3H-多巴胺。
Br J Pharmacol. 1968 Nov;34(3):514-22. doi: 10.1111/j.1476-5381.1968.tb08480.x.
8
Parkinsonism and DOPA.帕金森症与左旋多巴
Trans Assoc Am Physicians. 1968;81:171-83.
9
L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.左旋多巴（L-3,4-二羟基苯丙氨酸）——其在帕金森病中的临床疗效。
Trans Am Neurol Assoc. 1968;93:56-63.
10
Lithium.锂
Lancet. 1969 Jul 26;2(7613):212-3. doi: 10.1016/s0140-6736(69)91446-9.
Zotero 插件